New: Clinical trial search, funded by the National Cancer Institute
New: NCI-funded clinical trial search
Community
Tools
Company
Support
Sign in
Join for Free
Join for Free
Community
In patients with UGT1A1 Heterozygous 1*/28* status, what dose of Irinotecan do you use?
Broadly, how does UGT1A1 testing impact your irinotecan dosing?
Good Question
1
Save
Request Answers
Share
Add Answer
